Reijneveld, J. C.
814  results:
?
 
?
 
?
 
?
4

PL02.4.A International validation study of an EORTC instrum..:

Oort, Q ; Koekkoek, J ; Aaronson, N K...
Neuro-Oncology.  24 (2022)  Supplement_2 - p. ii3-ii3 , 2022
 
?
 
?
8

OS7.2 Measuring change in health-related quality of life: t..:

Coomans, M ; Taphoorn, M J B ; Aaronson, N...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii14-iii14 , 2019
 
?
 
?
11

OS7.4 Calculating the net clinical benefit in brain tumor c..:

Coomans, M ; Dirven, L ; Bottomley, A...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii14-iii15 , 2019
 
?
12

OS3.3 Development of an EORTC questionnaire measuring instr..:

Oort, Q ; Dirven, L ; Boele, F...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii9-iii9 , 2019
 
?
13

OS7.5 Healthcare utilization, medication use, and productiv..:

Boele, F W ; Jansen, F ; Meads, D...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii15-iii15 , 2019
 
?
14

P14.53 Deconstructing pathologically increased MEG network ..:

Kulik, S D ; Derks, J ; Numan, T...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii79-iii79 , 2019
 
?
15

OS6.1Glioma anatomic location and clinical phenotype relate..:

Numan, T ; Derks, J ; de Witt Hamer, P C...
Neuro-Oncology.  20 (2018)  suppl_3 - p. iii225-iii226 , 2018
 
1-15